Cortechs.ai | Custom lesion segmentation in LesionQuant 2.3

Custom lesion segmentation in LesionQuant 2.3

The 2.3 LesionQuant module of NeuroQuant (FDA cleared, CE marked) makes it easy for physicians to configure two specific lesion segmentation parameters to help define lesions during their review and to aid in their assessment of disease activity on MRIs from new and enlarging T2 FLAIR lesions.

User Configured Lesion Segmentation Parameters

  • Minimum Lesion Size:  For LesionQuant, a lesion is defined as a volume greater than 4 mm3, which appears brighter than gray matter and white matter on a 2D or 3D T2 FLAIR image. The default setting for lesion size is 4 mm3. However, users can set this parameter from 4 mm3 to 64 mm3, in order to increase the minimum size of a lesion being reported in the output.
  • Minimum Lesion Separation:  LesionQuant defines separate lesions as 1 mm voxels away from another lesion. The default setting for lesion separation is 3 mm, however, users can set this parameter between 1 and 5 mm. We recommend 2 mm for 3D/3T images and 3 mm for other scanner teslas and images.

Modifying the Lesion Segmentation Parameters
To configure these parameters, LesionQuant users can set their desired lesion segmentation settings for both lesion size and lesion separation in the Site Configuration tab in the user interface.

The selected lesion segmentation settings, for both current and prior scans, will be displayed on the top of the LesionQuant report.

Cortechs.ai | Custom lesion segmentation in LesionQuant 2.3

Want to learn more about LesionQuant?
We recently had a webinar to discuss the new features available in the LesionQuant from our latest software release. We also examined with case studies how the LesionQuant can help physicians quantify brain structure and lesions and as well as help in effectively evaluating disease activity in MS, based on current guidelines and research.

Our LesionQuant white paper provides more information about the accuracy and reproducibility available using LesionQuant for fully automated FLAIR lesion segmentation.

Do you have a technical question or support need?
The Cortechs.ai Support Team is available Monday through Friday from 7 AM to 5 PM PT.  Emailing support@cortechlabls.com is the easiest and best way to reach the Cortechs.ai Support Team during and after hours. Sending an email directly to a specific team member may result in delayed response time.

More Resources

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

02/19/2026

How Cortechs.ai Protects ePHI: HIPAA‑Aligned Controls—and Beyond

Cortechs.ai’s HIPAA-aligned, defense-in-depth security safeguards ePHI across AI workflows—exceeding baseline compliance standards.

02/11/2026

NeuroQuant Normative Database: Advancing Age‑ and Sex‑Specific Brain Volumetry

Learn how the latest updates to the NeuroQuant normative database white paper strengthen age- and sex-specific brain volumetry and enhance clinical confidence.
Scroll to Top